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Three-dimensional bio-printing and bone
tissue engineering: technical innovations
and potential applications in maxillofacial
reconstructive surgery
Muhja Salah1, Lobat Tayebi2, Keyvan Moharamzadeh3 and Farhad B. Naini4*
Abstract
Background: Bone grafting has been considered the gold standard for hard tissue reconstructive surgery and is
widely used for large mandibular defect reconstruction. However, the midface encompasses delicate structures that
are surrounded by a complex bone architecture, which makes bone grafting using traditional methods very
challenging. Three-dimensional (3D) bioprinting is a developing technology that is derived from the evolution of
additive manufacturing. It enables precise development of a scaffold from different available biomaterials that
mimic the shape, size, and dimension of a defect without relying only on the surgeon’s skills and capabilities, and
subsequently, may enhance surgical outcomes and, in turn, patient satisfaction and quality of life.
Review: This review summarizes different biomaterial classes that can be used in 3D bioprinters as bioinks to
fabricate bone scaffolds, including polymers, bioceramics, and composites. It also describes the advantages and
limitations of the three currently used 3D bioprinting technologies: inkjet bioprinting, micro-extrusion, and laser-
assisted bioprinting.
Conclusions: Although 3D bioprinting technology is still in its infancy and requires further development and
optimization both in biomaterials and techniques, it offers great promise and potential for facial reconstruction with
improved outcome.
Keywords: Facial reconstruction, Bone graft, Bone tissue engineering, Additive manufacturing, Bioactive scaffolds,
3D bioprinting, Bioink
Background
Developmental or acquired craniofacial deformities may
impose a negative psychological impact on affected indi-
viduals [1]. Such deformities affect the soft and the hard
tissues of the craniofacial complex to varying extents.
Managing such patients requires multidisciplinary care,
with the patient under the care of a team of specialists that
may involve a cranio-maxillofacial surgeon, plastic and
reconstructive surgeon, otorhinolaryngological surgeon,
neurosurgeon, pediatrician, orthodontist, psychologist and
speech and language therapist. Combined specialists’ ef-
fort is needed to improve function and aesthetics.
Surgery and bone grafting are considered crucial pil-
lars for repair when missing large amounts of bone [2].
Bone grafts may be harvested from the patient as an au-
tologous graft, which has the advantage of being bio-
compatible and not eliciting an immune response or
provoking graft rejection. Alternatively, allogenic bone
can be harvested from cadavers and transplanted into re-
cipients, which carries the risk of rejection. Bone can
also be replaced using natural or synthetic bone substi-
tutes [3]. Grafts provide support to the soft tissue
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overlaying it, improving the aesthetics and allowing for
the healing process to occur by “creeping substitution,”
which is the resorption of graft and its replacement with
new bone [4]. This is accomplished by the ability of the
graft to osteoinduce and osteoconduct the healing
process. Osteoinduction entails stimulation of progenitor
cells to differentiate into osteoblasts and enhance bone
deposition, while osteoconduction means providing a
surface on which the new bone will be deposited to dir-
ect the bone growth and restore its shape [5, 6].
For the bone graft to be successful, it should match
the shape and size of the replaced bone, in order to offer
the support and conduct the new bone formation [7].
Craniofacial bones have a complex architecture that en-
compasses spaces and contains delicate organs, and
shaping a bone graft in the traditional way with bone
trimming requires burs that will not allow replication of
the exact facial bone intended to be replaced [8]. Trans-
planting a graft that does not mimic the original shape
of the bone will negatively affect the outcome of the fa-
cial reconstructive surgery. Therefore, developing an ap-
propriate scaffold material to replace bone along with
the appropriate technique has been the focus of ongoing
research in the last decade.
Bone tissue engineering has been an avenue of scientific
interest since the 1980s [9, 10]. It aims to fabricate substi-
tutes for bone grafts using a scaffold from a biocompatible
material that carries the osteogenic cells needed for heal-
ing along with the growth factors that will help the osteo-
differentiation and angiogenesis to aid in the healing
process [11]. Since then, many biomaterials have been de-
veloped and tested to fulfill the requirement needed for
safety, adequate mechanical properties and designs to
mimic the replaced bone [12, 13].
Many methods have been utilized to fabricate scaffolds
for tissue engineering, including solvent casting and par-
ticulate leaching (SCPL), phase separation, gas foaming,
microsphere sintering and electrospinning [14, 15].
Though these methods are able to produce a scaffold
out of biomaterial, they are unable to precisely depict
the design they are intended to replace. Fortunately, the
collaboration between scientists and engineers, together
with interdisciplinary research, led to significant devel-
opments. Early in the 1970s, advances in design and
manufacturing technology led to the development of the
CAD/CAM system (computer-aided design/computer-
aided manufacturing), which was adopted and imple-
mented heavily in the automotive and aerospace indus-
tries [16]. The system produces a digital design using
software, and then with the assistance of the computer,
a prototype is manufactured. The technology made its
way into dentistry where it is still utilized for the fabrica-
tion of various fixed partial dentures and restorations re-
quiring better aesthetic appearance and durability [17].
Manufacturing those prototypes depends on carving the
design from an ingot or a block of material using the
CAM system [18, 19]. Scaffolds, on the other hand, re-
quire having interconnected pores to ensure infiltration
with nutrients and ensure cell migration within the ma-
terial to allow for replacement with healing cells [20].
Advances in manufacturing continued, and additive
manufacturing (AM) or three-dimensional (3D) printing,
was introduced into industry and biology. The AM tech-
nology fabricates the prototype or scaffold by depositing
bioink in a layer by layer manner rather than subtracting
from an ingot [21, 22]. Bioink is a material that resem-
bles the extracellular matrix containing cells encapsu-
lated within, which is then deposited with precision and
polymerizes or cross-links either before or after depos-
ition to form the scaffold [23]. Previously, the technology
was used to deposit a single bioink but nowadays and
with the advancement of the field, multicomponent
bioinks may now be deposited in high accuracy to mimic
the complex architecture of human tissue [24]. Recently,
the CAD technology combined with the advances in the
AM and 3D bioprinting technology has succeeded in the
construction of scaffolds for tissue regeneration that was
translated and implanted in patients for the repair of the
blood vessels, urethra, urinary bladder, and trachea [25].
The present review introduces both the bioink mater-
ial and the technology used in 3D bioprinting in relation
to maxillofacial plastic and reconstructive surgery.
Bioink material
The first generation of bioinks are materials that show
bioinert behavior and biocompatibility, which do not elicit
an immune response or rejection. In contrast, the body
only responds by forming a thick fiber capsule; thus, the
scaffold remains implanted without degrading and con-
tinues to provide mechanical support, e.g. metals (stainless
steel and titanium) and polymers (silicone and poly-
methylmethacrylate) [26]. The second generation of
bioinks are materials demonstrating both biocompatibility
and being bioactive. They allow mineralization, i.e. hy-
droxyapatite formation and are able to be biodegradable
for healing cells to replace the scaffold [27]. The third gen-
eration of bioinks is the bioresponsive materials, which in-
corporate growth factors and stimulatory molecules that
stimulate osteoblast differentiation including bone mor-
phogenetic proteins (BMP) and fibroblast growth factors
(FGF) [28]. Nowadays, a multicomponent bioink is used,
as it combines the mechanical and functional properties
to meet the complex need within the replaced tissue [24].
Biomaterials used for scaffold construction
Polymers
Polymers are an organic material made of repeated sub-
units, called monomers, bonded together with covalent
Salah et al. Maxillofacial Plastic and Reconstructive Surgery           (2020) 42:18 Page 2 of 9
bonds and composed mainly of carbon atoms [29]. They
are a versatile material that has shown to be both bio-
compatible and biodegradable, with the ability to change
its mechanical properties by altering its chemical struc-
ture. It can be highly viscous, such as hydrogel polymer,
or it can be stiffer to produce a stronger scaffold, such
as polycaprolactone (PCL) [30]. Yet, the mechanical
properties of the polymer depend on the tissue it is re-
placing and the method of 3D printing [31]. If inkjet
printing is used, stiff bioink can clog the nozzle of the
printer as the ink is deposited. This could be managed
by depositing unpolymerized ink that solidifies and
cross-links after deposition.
Polymer materials are either natural or synthetic. Nat-
ural polymers include proteins (e.g. silk, gelatin and col-
lagen) and polysaccharides (e.g. alginate, agarose and
chitosan). Polysaccharide polymers provide a lower anti-
genicity, but also have lesser mechanical properties than
protein polymers [32]. On the other hand, polyhydroxy
acids are synthetic polymers, such as polylactic acid
(PLA), polyglycolic acid (PGA) and polylactic-glycolic
acid (PLGA) [33, 34]. They are successful in producing a
porous scaffold, but biodegrade after implantation to
produce lactic acid and carbon dioxide. These bypro-
ducts can be easily removed from the body; however,
they simultaneously produce an acidic environment that
favors inflammation instead of healing [35]. Polycapro-
lactone (PCL) is a synthetic polymer that is found to bio-
degrade safely by hydrolysis degradation, thus not
negatively affecting the tissue environment, unlike the
polyhydroxy acid polymers [36]. It also has a low melting
point, making it compatible with encapsulating live cells
while being deposited without affecting their viability.
Bioceramics
Ceramics are inorganic materials in the form of bioactive
glass (BG), metal oxides or bioactive ceramics developed
for medical and dental use to replace bone [37]. BGs are
composed of silicon dioxide or silicate with sodium di-
oxide, calcium oxide and phosphorus [38]. They induce
hydroxyapatite (Hap) formation after contacting bio-
logical fluid, thus enhancing osteogenesis and bone heal-
ing [39]. On the other hand, bioactive glass ceramics
(e.g. Hap and tricalcium phosphate) are materials that
bond directly with bone without the formation of an
intermediate fibrous connective tissue layer [40]. Bio-
ceramic materials are brittle, have a low mechanical
strength and low fracture toughness and thus cannot be
used solely for scaffold fabrication [6].
Composites
A composite material is a mixture of two or more differ-
ent materials with the intent to manipulate the mechan-
ical properties of the end material utilizing the
properties of the initial materials used [41]. The compos-
ite is formed of polymer mixtures or polymer-ceramic
mixture. For example, mixing PCL with Hap enhances
the brittleness of the Hap and decreases the hydrophobi-
city of the PCL, thus increasing cell attachment and cell
infiltration into the scaffold [42].
Stem cells and bioactive molecules
For the biomaterial to be a bioink, they should encapsu-
late stem cells that can differentiate into different line-
ages and assist in the body healing and regeneration
[43]. Stem cells may be embryonic (ESC) in origin,
which carry the ethical considerations of harvesting
them using embryos [44]. Alternatively, adult stem cells
may be found in specific niches within the adult body,
such as the bone marrow, umbilical cord, amniotic tis-
sue, dental pulp and adipose tissue. Shen et al. compared
the osteogenic differentiation potential of different mes-
enchymal stem cell (MSC) sources and determined that
MSC derived from the amniotic membrane and umbil-
ical cord tissue has the highest osteogenic potential
compared with other MSC-derived cells [45]. Bioactive
molecules incorporated within the bioink are growth
factors that enhance angiogenesis, as in vascular endo-
thelial growth factor (VEGF), or may also improve osteo-
genic differentiation and bone formation, as in BMP,
FGF and insulin-like growth factor-1 (IGF-1) [23].
Bioprinting process
Bioprinting is an additive manufacturing (AM) process
in which the bioink, containing the ECM-like material
with encapsulated stem cells and active molecules, is de-
posited in the precise location with the aid of the CAD
system to form the scaffold. This facilitates the restor-
ation of the complex micro-environment of the native
tissue to enhance healing by cell differentiation, which is
called biomimicry [46]. Different modalities are used in
the 3D bioprinting to fabricate the scaffold, which are
the following (Fig. 1) [48].
Inkjet bioprinting (or drop-on-demand bioprinting)
The bioink in this printer is kept in a chamber above the
nozzle where it is subjected to a change in pressure cre-
ated by heating the bioink, which subsequently leads to
the ejection of a drop of the bioink into a platform be-
neath the nozzle. The high heat required to create this
pressure affects cell viability [49]. Otherwise, the chamber
is subjected to an acoustic wave through the piezoelectric
actuator, which causes a change in volume and, again,
ejection of a drop of bioink through the nozzle [50].
The bioink material used with this printer should be
viscous enough not to clog the nozzle, yet rigid enough
that can withstand different mechanical stresses. One
way to accomplish this is leaving the polymerization of
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the bioink to occur after it is deposited by the nozzle,
which can negatively affect the fidelity of the construct
[51]. Alternatively, a bioink with shear-thinning proper-
ties can be obtained, as in incorporating gelatin or colla-
gen into the bioink [52]. Both inkjet printers have the
advantage of the ability to create gradients of cell, mater-
ial and growth factors by altering the size and shape of
the droplet. A multi-nozzle printer has been developed
to speed up the printing process and enable the printing
of larger scaffolds [53].
Scientists have successfully printed neural, skin and
cardiac tissue using the inkjet printer [50, 54, 55]. Re-
garding bone tissue engineering, 3D printing scaffolds
for long bone reconstruction fabricated from different
biomaterials proved to be effective [56]. Gao et al. fab-
ricated bone tissue using the inkjet 3D bioprinting
technology with polyethylene glycol dimethacrylate
bioink and combined it with bone marrow-derived
mesenchymal stem cells (BM-MSC). They further
added either hydroxyapatite (Hap) or bioactive glass
(BG) nanoparticles to compare their difference in en-
hancing the osteogenic potential of the bioink
material. They found that fabricated scaffold with
(Hap) had more osteogenic potential measured by al-
kaline phosphatase activity than scaffolds fabricated
with the addition of BG [57]. Inzana et al. used inkjet
printer to fabricate scaffold from calcium phosphate
and implanted them on created femoral defect on ani-
mal models. They followed-up the defect to assess the
healing and implants were shown to have an osteocon-
ductive capacity with the ability of being self-
degrading without adverse effect [58]. In human clin-
ical trials, Saijo et al. fabricated scaffold from TCP
powder using inkjet printer and implanted them in ten
patients suffering from different maxillofacial defects.
They reported the successful results ranged from the
decrease in the operation time, the efficacy of the scaf-
fold and its union with the surrounding bone and the
negative overall adverse effect on these patients [59].
A Chinese scientist team also published their clinical
trial report of using 3D-bioprinted titanium scaffold
for treating different maxillofacial bone defects and
mandibular osteotomy. Again, they reported shorter
operation time and good aesthetic results [60].
Fig. 1 Schematic representation of the 3D bioprinting techniques: a inkjet bioprinting, b micro-extrusion bioprinting, and c laser-assisted
bioprinting (modified and adapted from Visscher et al.) [47]
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Extrusion bioprinting or filament printing
Like the inkjet printer, the bioink is stored in a chamber
in the printer head, but, unlike the inkjet, a continuous
filament of material is deposited on the platform and
over a material layer to form the scaffold. It enables the
use of highly viscous bioink that contains high cell dens-
ity. It uses a dispenser system having a pneumatic, pis-
ton or screw and valve that creates large pressure on
cells during extrusion. To save the viability of encapsu-
lated cells, hydrogel is used to create a shear-thinning ef-
fect and allows easier passage of the cells through the
nozzle and into the platform [61]. Saving the cell viabil-
ity by adding the hydrogel affects the resolution of the
constructed scaffold; thus, carefully choosing the bioink
and its viscosity along with the nozzle diameter is
needed to achieve the specific shape and size [62]. Many
natural and synthetic bioinks having different properties
had been tested for scaffold fabrication using the micro-
extrusion printer [63].
Micro-extrusion printers have successfully printed car-
tilage, and scientists were able to develop ear and auricu-
lar cartilage using PCL mixed with cell-laden hydrogel
[64]. Goh et al. used the same material PCL and the
micro-extrusion technology to fabricate scaffolds to
be placed on patient’s teeth extraction sites with the
aim of preserving alveolar ridge height for later im-
plant treatment [65]. They reported better preserva-
tion of alveolar height compared to patients who did
not receive the PCL scaffold and caused a decrease in
the alveolar ridge height.
Although micro-extrusion bioprinting is able to pro-
duce high cell density, it still carries the problem of the
decreased resolution and lower cell viability hindering its
translation.
Laser-assisted bioprinting (LAB)
This is a nozzle-free technique; therefore, no nozzle
clogging issue is encountered. The bioprinter is com-
posed of a pulsated laser, a printer donor ribbon having
two layers, an energy-absorbing layer and layer contain-
ing the bioink, which is heated by the laser and increases
its pressure, causing a drop to be released. Lastly, there
is a receiving substrate coated with hydrogel to cushion
the falling drops of bioink and preserve its fidelity [66].
Some studies found that laser directly decrease the cell
viability, but others demonstrated that an increase in the
film thickness and viscosity of the bioink would rescue
the cells and increase its viability [67, 68]. Gruene et al.
studied the effect of using the ND:YAG-laser on the
MSC viability laden in hydrogel used to construct 3D-
bioprinted scaffold [69]. They found that laser caused an
insignificant effect on the MSC’s viability and its ability
to differentiate into osteocyte and chondrocyte.
Optimizing the physical parameters of this bioprinter
and the bioink prove that laser bioprinting produces
scaffolds with high resolution, as high as cell per drop.
Unger et al. used time-resolved imaging to show the
resolution of the scaffold by following the vapor bubble
kinetics produced by the laser pulse until it causes the
drop of bioink material into the collector slide [70].
Guillotin et al. defined the highest cell resolution bio-
printing as producing a continuous line of cells in which
cells are printed and placed one by one at the desired
coordinate [71]. In their study, they deposited cells in
rows utilizing laser bioprinter in a predefined location
using computer-assisted geometric control with the
highest precision and they also explained the dynamic
and kinetics by which the bubble vapor and the pro-
duced bioink ejection occur. With the success of the 3D
printing using the LAB, Michael et al. used it to fabricate
skin by printing 20 layers of fibroblasts suspended in
collagen above 20 layers of keratinocyte suspended in
collagen and tested implantation of these construct on
mice [72]. Mice had been followed-up for 11 days, and
the constructs showed proper integration with the sur-
rounding tissues.
In bone tissue engineering, Roskies et al. created defects
on rabbit mandibles and reconstructed these defects using
scaffolds fabricated from polyetherketoneketone (PEKK)
combined with adipose-derived stem cell using LAB
technology [73]. They followed their animals at 10-
week and 20-week time, and they found proper inte-
gration of the implanted scaffold with the surround-
ing bone structure using CT scans and histological
tests. Keriquel et al. moved a step ahead and devel-
oped a protocol using LAB for in situ bone bioprint-
ing on mice to help precise positioning of cells for
defect reconstruction [47]. The bone scaffold was fab-
ricated from collagen and hydroxyapatite along with
MSC to ensure its osteoconductivity. They tested the
printing designs in vitro before applying and adapting
the measurement to suit mice calvarial defects.
Other factors for successful scaffold design
The success of the fabricated scaffold is markedly influ-
enced by the bioink chosen and the 3D bioprinting
chosen (Table 1) [48]. It also relies on other factors to
guarantee the success of the scaffold, which are as
follows:
Table 1 Bioprinting method and possible printable tissues
Inkjet bioprinting Micro-extrusion
bioprinting
Laser-assisted
bioprinting
Aponeuroses
Ear and nasal cartilage
Mimetic muscles
Blood vessels
Load-bearing bone
Cartilage
Muscle
Nerves
Skin
Blood vessels
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Pore size
The scaffold should interconnect pores to allow cell and
nutrient infiltration and removal of waste [74]. Pore size
further affects the cell migration and attachment along
the scaffold to replace it. Very small pore size hinders
the removal of waste and diffusion of nutrients while
bigger pore size hinders intercellular ligand formation
needed for cell migration. For bone tissue engineering, a
pore size ranging from 100 μm to sometimes greater
than 300 μm is needed as it provides the hypoxic condi-
tion that enhances both osteogenesis and angiogenesis
for proper bone formation [75]. Liu et al. developed a se-
quential seeding protocol on 3D-bioprinted natural and
synthetic scaffolds with human smooth muscle cells
followed by umbilical vein endothelial cells (both are pri-
mary cell types for blood vessels), and with the aid of a
bioreactor to ensure proper diffusion into the scaffold
[76]. Their method enhanced vascularization of the 3D-
printed scaffold as the presence of the smooth muscle
cells enhanced the attachment of the endothelial cells,
which can help forming a clinical-size scaffold.
Di Luca et al. investigated variating the scaffold pore
sizes to achieve the gradient of oxygen needed, more in
the peripheries and hypoxic at the center, and their in-
fluence on MSC differentiation [77]. The same hypoth-
esis was also tested by Abbasi et al. and both studies
concluded that using the gradient in pore size has a fa-
vorable effect on bone tissue engineering [78]. Control-
ling the porosity is achieved using the high control of
the 3D printing and it also allows the formation of gradi-
ents that was hard to achieve using other scaffold tech-
niques [79].
Surface topography
Scaffold surface topography is found to have a direct ef-
fect on the MSC differentiation lineage and deciding its
fate. A study conducted by Grazianio et al. in which they
compared the use of smooth surface titanium scaffold,
concave textured PLGA scaffold and convex textured of
Hap scaffolds. They cultured MSC extracted from dental
pulp (DP-derived MSC), and after 30 days, they mea-
sured alkaline phosphatase activity, detected bone pro-
teins (osteocalcin and osteonectin) and observed cell
under SEM [80]. They found that concave surfaces
allowed for the most MSC differentiation into osteoblast
and new bone tissue formation, followed by the smooth
surface while, the least was found on the convex surface.
The other study was undertaken by Shen et al., where
they used the 3D printer to fabricate linear and wavy
PCL scaffold and found that wavy scaffold design had
higher osteogenic potential decided by having calcium
deposition, increase alkaline phosphatase activity and
osteocalcin staining [81]. The preference of the MSC for
concave surfaces could be explained by how concavities
provide a closer surface for cells allowing them to
clump-forming denser integrin cell adhesion. Integrin is
a molecule known to have a different effect on the cell;
mostly related here to the differentiation of the MSC is
integrin’s importance of signal transduction and passing
cue from outside to the nucleus causing osteogenic gene
expression [82].
Conclusion
Scaffold fabrication for bone tissue engineering depends
on many physical and chemical factors that cue simul-
taneously to ensure cell migration, proliferation,
vascularization, osteogenic differentiation and scaffold
degradation [83]. 3D bioprinting has proved to create
the interconnected pores and the surface topography
needed for bone tissue engineering, thereby overcoming
one of the main challenges and barriers that faced the
translation of technology [84]. Biomaterial combination,
as well as methods and techniques for every organ, still
need to be tested and assessed prior to their translation
into patient care [85]. ClinicalTrials.gov lists only one
clinical trial investigating the safety and efficacy of treat-
ing bone injuries using 3D scaffolds made from demi-
neralized bone matrix and seeded with bone marrow-
derived stem cells [86]. Apart from the bone tissue en-
gineering, several organs have been successfully engi-
neered and successfully transplanted into patients, such
as the trachea, urethra and blood vessels [87, 88].
One of the barriers that hinders the translation of the
technology is its high cost. However, once a bioprinter is
owned, fabricating scaffolds using the 3D printing is
relatively cost-effective as only the necessary material is
used with minimal waste [89]. A bioengineering research
group has overcome this barrier by describing a method
to modify an off-the-shelf 3D printer into a printer for
bio-fabrication use [90].
The technology of 3D printing is promising and allows
for individualized medicine that is currently progressing.
Researchers are continuing to improve and develop the
deficits seen with tissue 3D bioprinting. Ultimately, 3D
printing technology is likely to become, not far from
now, an essential tool for maxillofacial, plastic and re-
constructive surgeons potentially to improve facial re-
construction surgical outcomes, along with patient
satisfaction and the quality of life of patients.
Abbreviations
3D bioprinting: Three-dimensional bioprinting; AM: Additive manufacturing;
BG: Bioactive glass; BMP: Bone morphogenic protein; CAD/CAM: Computer-
aided design/computer-aided manufacturing; ECM: Extracellular matrix;
FGF: Fibroblast growth factor; Hap: Hydroxyapatite; IGF: Insulin-like growth
factor; LAB: Laser-assisted bioprinting; MSC: Mesenchymal stem cell;
PCL: Polycaprolactone; PGA: Polyglycolic acid; PLA: Polylactic acid;
PLGA: Polylactic-glycolic acid; SCPL: Solvent casting and particulate leaching;
VEGF: Vascular epithelial growth factor
Salah et al. Maxillofacial Plastic and Reconstructive Surgery           (2020) 42:18 Page 6 of 9
Acknowledgements
LT and KM acknowledge the financial support from the National Institute of
Dental & Craniofacial Research of the National Institutes of Health under
award number R15DE027533.
Authors’ contributions
MY prepared the first draft the review article, and LT, KM and FBN
contributed to the final manuscript. The authors reviewed the final
manuscript. The author(s) read and approved the final manuscript.
Funding
National Institute of Dental & Craniofacial Research of the National Institutes
of Health under award number R15DE027533.
Availability of data and materials
Not applicable.
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Author details
1St George’s Hospital, London, UK. 2Marquette University School of Dentistry,
Milwaukee, WI, USA. 3Academic Unit of Restorative Dentistry, School of
Clinical Dentistry, University of Sheffield, Sheffield, UK. 4Kingston and St
George’s Hospitals and St George’s Medical School, London SW17 0QT, UK.
Received: 5 May 2020 Accepted: 24 May 2020
References
1. Singh VP, Moss TP (2015) Psychological impact of visible differences in
patients with congenital craniofacial anomalies. Prog Orthod 16:5–5. https://
doi.org/10.1186/s40510-015-0078-9
2. Elsalanty ME, Genecov DG (2009) Bone grafts in craniofacial surgery.
Craniomaxillofac Trauma Reconstr 2(3):125–134. https://doi.org/10.1055/s-
0029-1215875
3. Campana V, Milano G, Pagano E, Barba M, Cicione C, Salonna G, Lattanzi W,
Logroscino G (2014) Bone substitutes in orthopaedic surgery: from basic
science to clinical practice. J Mater Sci Mater Med 25(10):2445–2461. https://
doi.org/10.1007/s10856-014-5240-2
4. Oppenheimer AJ, Tong L, Buchman SR (2008) Craniofacial bone grafting:
Wolff’s law revisited. Craniomaxillofac Trauma Reconstr 1(1):49–61. https://
doi.org/10.1055/s-0028-1098963
5. Albrektsson T, Johansson C (2001) Osteoinduction, osteoconduction and
osseointegration. Eur Spine J 10 Suppl 2(Suppl 2):S96–S101. https://doi.org/
10.1007/s005860100282
6. Lin K, Sheikh R, Romanazzo S, Roohani I (2019) 3D printing of bioceramic
scaffolds-barriers to the clinical translation: from promise to reality, and
future perspectives. Materials (Basel) 12(17):2660. https://doi.org/10.3390/
ma12172660
7. Lin K, Sheikh R, Romanazzo S, Roohani I (2019) 3D printing of bioceramic
scaffolds—barriers to the clinical translation: from promise to reality, and
future perspectives. Materials 12:2660. https://doi.org/10.3390/ma12172660
8. Mittal Y, Jindal G, Garg S (2016) Bone manipulation procedures in dental
implants. Indian J Dent 7(2):86–94. https://doi.org/10.4103/0975-962X.
184650
9. Amini AR, Laurencin CT, Nukavarapu SP (2012) Bone tissue engineering:
recent advances and challenges. Crit Rev Biomed Eng 40(5):363–408.
https://doi.org/10.1615/critrevbiomedeng.v40.i5.10
10. Kargozar S, Hashemian S, Soleimani M, Milan P, Askari M, Khalaj V,
Samadikuchaksaraei A, Hamzehlou S, Katebi A, Latifi N, Mozafari M, Baino F
(2017) Acceleration of bone regeneration in bioactive glass/gelatin
composite scaffolds seeded with bone marrow-derived mesenchymal stem
cells over-expressing bone morphogenetic protein-7. Materials Science and
Engineering: C 1:688–698. https://doi.org/10.1016/j.msec.2017.02.097
11. Awad HA, O’Keefe RJ, Lee CH, Mao JJ (2014) Chapter 83 - bone tissue
engineering: clinical challenges and emergent advances in orthopedic and
craniofacial surgery. In: Lanza R, Langer R, Vacanti J (eds) Principles of Tissue
Engineering (Fourth Edition). Academic Press, Boston, pp 1733-1743. doi:
https://doi.org/10.1016/B978-0-12-398358-9.00083-5
12. O'Brien FJ (2011) Biomaterials & scaffolds for tissue engineering. Materials
Today 14(3):88–95. https://doi.org/10.1016/S1369-7021(11)70058-X
13. Ghassemi T, Shahroodi A, Ebrahimzadeh MH, Mousavian A, Movaffagh J,
Moradi A (2018) Current concepts in scaffolding for bone tissue
engineering. Arch Bone Jt Surg 6(2):90–99
14. Chocholata P, Kulda V, Babuska V (2019) Fabrication of Scaffolds for bone-
tissue regeneration. Materials 12(4). https://doi.org/10.3390/ma12040568
15. Nyberg E, Rindone A, Dorafshar A, Grayson W (2016) Comparison of 3D-
printed poly- -caprolactone scaffolds functionalized with tricalcium
phosphate, hydroxyapatite, bio-oss, or decellularized bone matrix. Tissue
engineering Part A 23. https://doi.org/10.1089/ten.TEA.2016.0418
16. Scheitz CJF, Peck LJ, Groban ES (2018) Biotechnology software in the digital
age: are you winning? Journal of Industrial Microbiology & Biotechnology
45(7):529–534. https://doi.org/10.1007/s10295-018-2009-5
17. Miyazaki T, Hotta Y, Kunii J, Kuriyama S, Tamaki Y (2009) A review of dental
CAD/CAM: current status and future perspectives from 20 years of experience.
Dental materials journal 28:44–56. https://doi.org/10.4012/dmj.28.44
18. Tamrakar A, Rathee M, Mallick R, Dabas S (2014) CAD/CAM in
prosthodontics - a futuristic overview.
19. Lee K-H, Yeo I-S, Wu BM, Yang J-H, Han J-S, Kim S-H, Yi Y-J, Kwon T-K (2015)
Effects of computer-aided manufacturing technology on precision of clinical
metal-free restorations. Biomed Res Int 2015:619027–619027. https://doi.org/
10.1155/2015/619027
20. Loh QL, Choong C (2013) Three-dimensional scaffolds for tissue engineering
applications: role of porosity and pore size. Tissue Eng Part B Rev 19(6):485–
502. https://doi.org/10.1089/ten.TEB.2012.0437
21. https://www.autodesk.co.uk/solutions/cad-cam.
22. Gul M, Arif A, Ghafoor R (2019) Role of three-dimensional printing in
periodontal regeneration and repair: literature review. J Indian Soc
Periodontol 23(6):504–510. https://doi.org/10.4103/jisp.jisp_46_19
23. Gungor-Ozkerim PS, Inci I, Zhang YS, Khademhosseini A, Dokmeci MR (2018)
Bioinks for 3D bioprinting: an overview. Biomater Sci 6(5):915–946. https://
doi.org/10.1039/c7bm00765e
24. Ashammakhi N, Ahadian S, Xu C, Montazerian H, Ko H, Nasiri R, Barros N,
Khademhosseini A (2019) Bioinks and bioprinting technologies to make
heterogeneous and biomimetic tissue constructs. Materials Today Bio 1:
100008. https://doi.org/10.1016/j.mtbio.2019.100008
25. Jain A, Bansal R (2015) Applications of regenerative medicine in organ
transplantation. J Pharm Bioallied Sci 7(3):188–194. https://doi.org/10.4103/
0975-7406.160013
26. Mariani E, Lisignoli G, Borzì RM, Pulsatelli L (2019) Biomaterials: foreign
bodies or tuners for the immune response? Int J Mol Sci 20(3):636. https://
doi.org/10.3390/ijms20030636
27. Turnbull G, Clarke J, Picard F, Riches P, Jia L, Han F, Li B, Shu W (2018) 3D
bioactive composite scaffolds for bone tissue engineering. Bioactive
Materials 3(3):278–314. https://doi.org/10.1016/j.bioactmat.2017.10.001
28. Maisani M, Pezzoli D, Chassande O, Mantovani D (2017) Cellularizing
hydrogel-based scaffolds to repair bone tissue: how to create a
physiologically relevant micro-environment? Journal of Tissue Engineering
8:2041731417712073. https://doi.org/10.1177/2041731417712073
29. Padovani GCFVP, Sauro S, Tay FR, Durán G, Paula AJ, Durán N (2015)
Advances in dental materials through nanotechnology: facts, perspectives
and toxicological aspects. Trends Biotechnol 33:621–636
30. Polymeric scaffolds in tissue engineering application: a review (2011).
International Journal of Polymer Science 2011. doi:https://doi.org/10.1155/
2011/290602
31. Dizon JRC, Espera AH, Chen Q, Advincula RC (2018) Mechanical
characterization of 3D-printed polymers. Additive Manufacturing 20:44–67.
https://doi.org/10.1016/j.addma.2017.12.002
32. Tiwari S, Patil R, Bahadur P (2018) Polysaccharide based scaffolds for soft
tissue engineering applications. Polymers (Basel) 11(1):1. https://doi.org/10.
3390/polym11010001
33. Chocholata P, Kulda V, Babuska V (2019) Fabrication of scaffolds for bone-
tissue regeneration. Materials 12:568. https://doi.org/10.3390/ma12040568
34. Guduric V, Bareille R, Héroguez V, Latour S, L’Heureux N, Fricain JC, Catros S,
Le Nihouannen D (2017) Characterization of printed PLA scaffolds for bone
Salah et al. Maxillofacial Plastic and Reconstructive Surgery           (2020) 42:18 Page 7 of 9
tissue engineering. Journal of Biomedical Materials Research Part A:106.
https://doi.org/10.1002/jbm.a.36289
35. Ginjupalli K, Shavi G, Averineni R, Bhat M, Udupa N, Upadhya N (2017)
Poly(α-hydroxy acid) based polymers: a review on material and degradation
aspects. Polymer Degradation and Stability 144. https://doi.org/10.1016/j.
polymdegradstab.2017.08.024
36. Saad B, Suter UW (2001) Biodegradable polymeric materials. In: Buschow
KHJ, Cahn RW, Flemings MC et al (eds) Encyclopedia of Materials: Science
and Technology. Elsevier, Oxford, pp 551–555. https://doi.org/10.1016/B0-
08-043152-6/00105-4
37. Raghavendra SS, Jadhav GR, Gathani KM, Kotadia P (2017) Bioceramics in
endodontics - a review. J Istanb Univ Fac Dent 51 (3 Suppl 1):S128-S137.
doi:https://doi.org/10.17096/jiufd.63659
38. van Vugt TA, Geurts JAP, Arts JJ, Lindfors NC (2017) 3 - biomaterials in
treatment of orthopedic infections. In: Geurts J (ed) Arts JJC. Woodhead
Publishing, Management of Periprosthetic Joint Infections (PJIs), pp 41–68.
https://doi.org/10.1016/B978-0-08-100205-6.00003-3
39. Fernandes HR, Gaddam A, Rebelo A, Brazete D, Stan GE, Ferreira JMF (2018)
Bioactive glasses and glass-ceramics for healthcare applications in bone
regeneration and tissue engineering. Materials (Basel) 11(12):2530. https://
doi.org/10.3390/ma11122530
40. Ishikawa K, Matsuya S, Miyamoto Y, Kawate K (2003) 9.05 - bioceramics. In:
Milne I, Ritchie RO, Karihaloo B (eds) Comprehensive Structural Integrity.
Pergamon, Oxford, pp 169–214. https://doi.org/10.1016/B0-08-043749-4/
09146-1
41. Hölzl K, Lin S, Tytgat L, Van Vlierberghe S, Gu L, Ovsianikov A (2016) Bioink
properties before, during and after 3D bioprinting. Biofabrication 8. https://
doi.org/10.1088/1758-5090/8/3/032002
42. Rajzer I (2014) Fabrication of bioactive polycaprolactone/hydroxyapatite
scaffolds with final bilayer nano-/micro-fibrous structures for tissue
engineering application. Journal of Materials Science 49(16):5799–5807.
https://doi.org/10.1007/s10853-014-8311-3
43. Groll J, Burdick JA, Cho DW, Derby B, Gelinsky M, Heilshorn SC et al (2018) A
definition of bioinks and their distinction from biomaterial inks.
Biofabrication 11(1):013001. https://doi.org/10.1088/1758-5090/aaec52
44. Lo B, Parham L (2009) Ethical issues in stem cell research. Endocr Rev 30(3):
204–213. https://doi.org/10.1210/er.2008-0031
45. Shen C, Yang C, Xu S, Zhao H (2019) Comparison of osteogenic
differentiation capacity in mesenchymal stem cells derived from human
amniotic membrane (AM), umbilical cord (UC), chorionic membrane (CM),
and decidua (DC). Cell Biosci 9:17–17. https://doi.org/10.1186/s13578-019-
0281-3
46. Dang M, Saunders L, Niu X, Fan Y, Ma PX (2018) Biomimetic delivery of
signals for bone tissue engineering. Bone Research 6(1):25. https://doi.org/
10.1038/s41413-018-0025-8
47. Keriquel V, Oliveira H, Rémy M, Ziane S, Delmond S, Rousseau B et al (2017)
In situ printing of mesenchymal stromal cells, by laser-assisted bioprinting,
for in vivo bone regeneration applications. Scientific reports 7(1):1778–1778.
https://doi.org/10.1038/s41598-017-01914-x
48. Visscher DO, Farré-Guasch E, Helder MN, Gibbs S, Forouzanfar T, van Zuijlen
PP, Wolff J (2016) Advances in bioprinting technologies for craniofacial
reconstruction. Trends in Biotechnology 34(9):700–710. https://doi.org/10.
1016/j.tibtech.2016.04.001
49. Cui X, Boland T, D'Lima DD, Lotz MK (2012) Thermal inkjet printing in tissue
engineering and regenerative medicine. Recent Pat Drug Deliv Formul 6(2):
149–155. https://doi.org/10.2174/187221112800672949
50. Iwanaga S, Arai K, Nakamura M (2015) Chapter 4 - inkjet bioprinting. In:
Atala A, Yoo JJ (eds) Essentials of 3D Biofabrication and Translation.
Academic Press, Boston, pp 61–79. https://doi.org/10.1016/B978-0-12-
800972-7.00004-9
51. Hölzl K, Lin S, Tytgat L, Van Vlierberghe S, Gu L, Ovsianikov A (2016) Bioink
properties before, during and after 3D bioprinting. Biofabrication 8(3):
032002. https://doi.org/10.1088/1758-5090/8/3/032002
52. Derakhshanfar S, Mbeleck R, Xu K, Zhang X, Zhong W, Xing M (2018) 3D
bioprinting for biomedical devices and tissue engineering: a review of
recent trends and advances. Bioactive materials 3(2):144–156. https://doi.
org/10.1016/j.bioactmat.2017.11.008
53. Hansen CJ, Saksena R, Kolesky DB, Vericella JJ, Kranz SJ, Muldowney GP,
Christensen KT, Lewis JA (2013) High-throughput printing via microvascular
multinozzle arrays. Advanced Materials 25(1):96–102. https://doi.org/10.1002/
adma.201203321
54. Xu T, Baicu C, Aho M, Zile M, Boland T (2009) Fabrication and
characterization of bio-engineered cardiac pseudo tissues. Biofabrication
1(3):035001–035001. https://doi.org/10.1088/1758-5082/1/3/035001
55. Tse C, Whiteley R, Yu T, Stringer J, MacNeil S, Haycock JW, Smith PJ (2016)
Inkjet printing Schwann cells and neuronal analogue NG108-15 cells.
Biofabrication 8(1):015017. https://doi.org/10.1088/1758-5090/8/1/015017
56. Liao W, Xu L, Wangrao K, Du Y, Xiong Q, Yao Y (2019) Three-dimensional
printing with biomaterials in craniofacial and dental tissue engineering.
PeerJ 7:e7271. https://doi.org/10.7717/peerj.7271
57. Gao G, Schilling AF, Yonezawa T, Wang J, Dai G, Cui X (2014) Bioactive
nanoparticles stimulate bone tissue formation in bioprinted three-
dimensional scaffold and human mesenchymal stem cells. Biotechnology
Journal 9(10):1304–1311. https://doi.org/10.1002/biot.201400305
58. Inzana JA, Olvera D, Fuller SM, Kelly JP, Graeve OA, Schwarz EM, Kates SL,
Awad HA (2014) 3D printing of composite calcium phosphate and collagen
scaffolds for bone regeneration. Biomaterials 35(13):4026–4034. https://doi.
org/10.1016/j.biomaterials.2014.01.064
59. Saijo H, Igawa K, Kanno Y, Mori Y, Kondo K, Shimizu K et al (2009)
Maxillofacial reconstruction using custom-made artificial bones fabricated
by inkjet printing technology. Journal of Artificial Organs 12(3):200–205.
https://doi.org/10.1007/s10047-009-0462-7
60. Shen C, Zhang Y, Li Q, Zhu M, Hou Y, Qu M, Xu Y, Chai G (2014) Application
of three-dimensional printing technique in artificial bone fabrication for
bone defect after mandibular angle ostectomy. Zhongguo Xiu Fu Chong
Jian Wai Ke Za Zhi 28(3):300–303
61. Pati F, Jang J, Lee J-W, Cho d-w (2015) Extrusion bioprinting. In. pp 123-152.
doi:https://doi.org/10.1016/B978-0-12-800972-7.00007-4
62. Wüst S, Müller R, Hofmann S (2011) Controlled positioning of cells in
biomaterials-approaches towards 3D tissue printing. J Funct Biomater 2(3):
119–154. https://doi.org/10.3390/jfb2030119
63. Panwar A, Tan LP (2016) Current status of bioinks for micro-extrusion-based
3D bioprinting. Molecules (Basel, Switzerland) 21 (6):685. https://doi.org/10.
3390/molecules21060685
64. Lee J-S, Hong JM, Jung JW, Shim J-H, Oh J-H, Cho D-W (2014) 3D printing
of composite tissue with complex shape applied to ear regeneration.
Biofabrication 6(2):024103. https://doi.org/10.1088/1758-5082/6/2/024103
65. Goh BT, Teh LY, Tan DBP, Zhang Z, Teoh SH (2015) Novel 3D
polycaprolactone scaffold for ridge preservation – a pilot randomised
controlled clinical trial. Clinical Oral Implants Research 26(3):271–277. https://
doi.org/10.1111/clr.12486
66. Rider P, Kačarević ŽP, Alkildani S, Retnasingh S, Barbeck M (2018) Bioprinting
of tissue engineering scaffolds. Journal of tissue engineering 9:
2041731418802090–2041731418802090. https://doi.org/10.1177/
2041731418802090
67. Guillemot F, Souquet A, Catros S, Guillotin B (2010) Laser-assisted cell
printing: principle, physical parameters versus cell fate and perspectives in
tissue engineering. Nanomedicine 5(3):507–515. https://doi.org/10.2217/
nnm.10.14
68. Catros S, Guillotin B, Bacáková M, Fricain jc, Guillemot F (2011) Effect of laser
energy, substrate film thickness and bioink viscosity on viability of
endothelial cells printed by laser-assisted bioprinting. Applied Surface
Science - APPL SURF SCI 257:5142-5147. doi:https://doi.org/10.1016/j.apsusc.
2010.11.049
69. Gruene M, Deiwick A, Koch L, Schlie S, Unger C, Hofmann N et al (2011)
Laser printing of stem cells for biofabrication of scaffold-free autologous
grafts. Tissue Eng Part C Methods 17(1):79–87. https://doi.org/10.1089/ten.
TEC.2010.0359
70. Unger C, Gruene M, Koch L, Koch J, Chichkov BN (2011) Time-resolved
imaging of hydrogel printing via laser-induced forward transfer. Applied
Physics A 103(2):271–277. https://doi.org/10.1007/s00339-010-6030-4
71. Guillotin B, Souquet A, Catros S, Duocastella M, Pippenger B, Bellance S et al
(2010) Laser assisted bioprinting of engineered tissue with high cell density
and microscale organization. Biomaterials 31(28):7250–7256. https://doi.org/
10.1016/j.biomaterials.2010.05.055
72. Michael S, Sorg H, Peck C-T, Koch L, Deiwick A, Chichkov B, Vogt PM,
Reimers K (2013) Tissue engineered skin substitutes created by laser-assisted
bioprinting form skin-like structures in the dorsal skin fold chamber in mice.
PloS one 8(3):e57741–e57741. https://doi.org/10.1371/journal.pone.0057741
73. Roskies MG, Fang D, Abdallah M-N, Charbonneau AM, Cohen N, Jordan JO
et al (2017) Three-dimensionally printed polyetherketoneketone scaffolds
with mesenchymal stem cells for the reconstruction of critical-sized
Salah et al. Maxillofacial Plastic and Reconstructive Surgery           (2020) 42:18 Page 8 of 9
mandibular defects. The Laryngoscope 127(11):E392–E398. https://doi.org/
10.1002/lary.26781
74. Bružauskaitė I, Bironaitė D, Bagdonas E, Bernotienė E (2016) Scaffolds and
cells for tissue regeneration: different scaffold pore sizes-different cell
effects. Cytotechnology 68(3):355–369. https://doi.org/10.1007/s10616-015-
9895-4
75. Karageorgiou V, Kaplan D (2005) Porosity of 3D biomaterial scaffolds and
osteogenesis. Biomaterials 26(27):5474–5491. https://doi.org/10.1016/j.
biomaterials.2005.02.002
76. Liu X, Jakus AE, Kural M, Qian H, Engler A, Ghaedi M et al (2018)
Vascularization of Natural and Synthetic Bone Scaffolds. Cell Transplant
27(8):1269–1280. https://doi.org/10.1177/0963689718782452
77. Di Luca A, Ostrowska B, Lorenzo-Moldero I, Lepedda A, Swieszkowski W, Van
Blitterswijk C, Moroni L (2016) Gradients in pore size enhance the
osteogenic differentiation of human mesenchymal stromal cells in three-
dimensional scaffolds. Scientific Reports 6(1):22898. https://doi.org/10.1038/
srep22898
78. Abbasi N, Ivanovski S, Gulati K, Love RM, Hamlet S (2020) Role of offset and
gradient architectures of 3-D melt electrowritten scaffold on differentiation
and mineralization of osteoblasts. Biomater Res 24:2–2. https://doi.org/10.
1186/s40824-019-0180-z
79. Buj-Corral I, Bagheri A, Petit-Rojo O (2018) 3D printing of porous scaffolds
with controlled porosity and pore size values. Materials (Basel) 11(9):1532.
https://doi.org/10.3390/ma11091532
80. Graziano A, d’Aquino R, Angelis MGC-D, De Francesco F, Giordano A, Laino
G et al (2008) Scaffold’s surface geometry significantly affects human stem
cell bone tissue engineering. Journal of Cellular Physiology 214(1):166–172.
https://doi.org/10.1002/jcp.21175
81. Ji S, Guvendiren M (2019) 3D printed wavy scaffolds enhance mesenchymal
stem cell osteogenesis. Micromachines (Basel) 11(1):31. https://doi.org/10.
3390/mi11010031
82. Olivares-Navarrete R, Rodil SE, Hyzy SL, Dunn GR, Almaguer-Flores A,
Schwartz Z, Boyan BD (2015) Role of integrin subunits in mesenchymal
stem cell differentiation and osteoblast maturation on graphitic carbon-
coated microstructured surfaces. Biomaterials 51:69–79. https://doi.org/10.
1016/j.biomaterials.2015.01.035
83. Chen X, Fan H, Deng X, Wu L, Yi T, Gu L et al (2018) Scaffold structural
microenvironmental cues to guide tissue regeneration in bone tissue
applications. Nanomaterials (Basel) 8(11):960. https://doi.org/10.3390/
nano8110960
84. Bose S, Vahabzadeh S, Bandyopadhyay A (2013) Bone tissue engineering
using 3D printing. Materials Today 16(12):496–504. https://doi.org/10.1016/j.
mattod.2013.11.017
85. Hollister SJ, Murphy WL (2011) Scaffold translation: barriers between
concept and clinic. Tissue Eng Part B Rev 17(6):459–474. https://doi.org/10.
1089/ten.TEB.2011.0251
86. https://clinicaltrials.gov/ct2/show/NCT03103295.
87. Olson JL, Atala A, Yoo JJ (2011) Tissue engineering: current strategies and
future directions. Chonnam Med J 47(1):1–13. https://doi.org/10.4068/cmj.
2011.47.1.1
88. Maroulakos M, Kamperos G, Tayebi L, Halazonetis D, Ren Y (2019)
Applications of 3D printing on craniofacial bone repair: a systematic review.
Journal of Dentistry 80:1–14. https://doi.org/10.1016/j.jdent.2018.11.004
89. Ventola CL (2014) Medical applications for 3D printing: current and
projected uses. P T 39(10):704–711
90. Kahl M, Gertig M, Hoyer P, Friedrich O, Gilbert DF (2019) Ultra-low-cost 3D
bioprinting: modification and application of an off-the-shelf desktop 3D-
printer for biofabrication. Frontiers in Bioengineering and Biotechnology
7(184). https://doi.org/10.3389/fbioe.2019.00184
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Salah et al. Maxillofacial Plastic and Reconstructive Surgery           (2020) 42:18 Page 9 of 9
